Search research articles
Contact Us
Filters
Showing results (11-20 of 98) with videos related to
Page
of 10
Sort By:
Vaccine
|
December 21, 2019
Cost-effectiveness analysis for rotavirus vaccine decision-making: How can we best inform evolving and complex choices in vaccine product selection?
Clint Pecenka, Frederic Debellut, Naor Bar-Zeev, et al.
Plos One
|
December 10, 2015
Health Gains and Financial Protection from Pneumococcal Vaccination and Pneumonia Treatment in Ethiopia: Results from an Extended Cost-Effectiveness Analysis
Kjell Arne Johansson, Solomon Tessema Memirie, Clint Pecenka, et al.
Vaccine: X
|
August 26, 2024
Determinants of costs of human papillomavirus vaccine delivery in six low- and middle-income countries
Mercy Mvundura, Rose Slavkovsky, Frédéric Debellut, et al.
BMC Public Health
|
May 7, 2020
Cost of illness for childhood diarrhea in low- and middle-income countries: a systematic review of evidence and modelled estimates
Ranju Baral, Justice Nonvignon, Frédéric Debellut, et al.
Plos One
|
June 25, 2024
The cost of typhoid illness in low- and middle-income countries, a scoping review of the literature
Frederic Debellut, Alena Friedrich, Ranju Baral, et al.
Vaccine: X
|
December 5, 2024
Cost of the typhoid conjugate vaccine introduction through an integrated campaign and follow-on routine immunization in Malawi
Frédéric Debellut, George Bello, Mike Chisema, et al.
Journal of Global Health
|
April 10, 2025
Estimating the economic burden of respiratory syncytial virus infection among children <2 years old receiving care in Maputo, Mozambique
Neele Rave, Tufária Mussá, An Nguyen, et al.
BMC Medicine
|
April 10, 2023
Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low-income and middle-income countries
Sarwat Mahmud, Ranju Baral, Colin Sanderson, et al.
BMJ Global Health
|
December 17, 2021
Pneumococcal conjugate vaccination in The Gambia: health impact, cost effectiveness and budget implications
Clint Pecenka, Effua Usuf, Ilias Hossain, et al.
Journal of Global Health
|
May 29, 2026
The economic burden of respiratory syncytial virus and other acute respiratory infections among children <2 years old seeking care at a tertiary facility in Accra, Ghana
Farina Leonie Shaaban, Joycelyn Dame, An Nguyen, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 98) with videos related to
Sort By:
Page
of 10
Vaccine
|
December 21, 2019
Cost-effectiveness analysis for rotavirus vaccine decision-making: How can we best inform evolving and complex choices in vaccine product selection?
Clint Pecenka, Frederic Debellut, Naor Bar-Zeev, et al.
Plos One
|
December 10, 2015
Health Gains and Financial Protection from Pneumococcal Vaccination and Pneumonia Treatment in Ethiopia: Results from an Extended Cost-Effectiveness Analysis
Kjell Arne Johansson, Solomon Tessema Memirie, Clint Pecenka, et al.
Vaccine: X
|
August 26, 2024
Determinants of costs of human papillomavirus vaccine delivery in six low- and middle-income countries
Mercy Mvundura, Rose Slavkovsky, Frédéric Debellut, et al.
BMC Public Health
|
May 7, 2020
Cost of illness for childhood diarrhea in low- and middle-income countries: a systematic review of evidence and modelled estimates
Ranju Baral, Justice Nonvignon, Frédéric Debellut, et al.
Plos One
|
June 25, 2024
The cost of typhoid illness in low- and middle-income countries, a scoping review of the literature
Frederic Debellut, Alena Friedrich, Ranju Baral, et al.
Vaccine: X
|
December 5, 2024
Cost of the typhoid conjugate vaccine introduction through an integrated campaign and follow-on routine immunization in Malawi
Frédéric Debellut, George Bello, Mike Chisema, et al.
Journal of Global Health
|
April 10, 2025
Estimating the economic burden of respiratory syncytial virus infection among children <2 years old receiving care in Maputo, Mozambique
Neele Rave, Tufária Mussá, An Nguyen, et al.
BMC Medicine
|
April 10, 2023
Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low-income and middle-income countries
Sarwat Mahmud, Ranju Baral, Colin Sanderson, et al.
BMJ Global Health
|
December 17, 2021
Pneumococcal conjugate vaccination in The Gambia: health impact, cost effectiveness and budget implications
Clint Pecenka, Effua Usuf, Ilias Hossain, et al.
Journal of Global Health
|
May 29, 2026
The economic burden of respiratory syncytial virus and other acute respiratory infections among children <2 years old seeking care at a tertiary facility in Accra, Ghana
Farina Leonie Shaaban, Joycelyn Dame, An Nguyen, et al.
Page
of 10